19674-1-AP

antibody from Proteintech Group

Targeting: COL4A4 CA44

ELISA (Data presented on provider website)

Immunocytochemistry (Data presented on provider website)

Antibody Data

Product number

19674-1-AP

Provider

Proteintech Group

Product name

Collagen Type IV antibody

Antibody type

Polyclonal

Description

Collagen Type IV antibody (Cat. #19674-1-AP) is a rabbit polyclonal antibody that shows reactivity with human and has been validated for the following applications: IF,ELISA.

Reactivity

Human

Host

Rabbit

Conjugate

Unconjugated

Isotype

IgG

Vial size

20ul, 150ul

References

Submitted references

PAPPA2 c.392G>C Heterozygous Mutation Associates Primary Open-Angle Glaucoma in a Chinese Family.

Wang G, Guo Z, Ren J, Zhang G, Tao H, Liu Y, Zheng S, Zhang X, Wang D, Zhao R, Cui H, Zhu S, Xu H, Duan S, Li H
Human mutation 2026;2026:5591097

---

Kaempferol improves mitochondrial homeostasis via mitochondrial dynamics and mitophagy in diabetic kidney disease.

Xia C, Zhang J, Chen H, Jiang W, Zhou S, Zheng H, Sun W
International immunopharmacology 2025 Sep 23;162:115121

---

Dapagliflozin ameliorates high glucose-induced peritoneal fibrosis through downregulation of ENKUR/PI3K/AKT signaling pathway.

Liu J, Xu X, Zhang L, Jiang T, Zhao Z, Xiao J
Scientific reports 2025 Nov 3;15(1):38334

---

Huangkui capsule, an extract from Abelmoschus manihot (L.) medic, inhibits adrenal aldosterone synthesis and renal ERK/EGR1 pathway in the treatment of diabetic kidney disease.

Saxu R, Tang H, Yu H, Ge H, Gu HF
Journal of ethnopharmacology 2025 Jun 12;349:119936

---

Blocking TSP1 Ameliorates Diabetes Mellitus-Induced Erectile Dysfunction by Inhibiting the TGF-β/SMAD Pathway.

Xia M, Yuan Y, Fang D, Tan X, Zhao F, Li X, Gao P, Zhou Z, Nan T, Xin Z, Li X, Guan R
The world journal of men's health 2025 Jul;43(3):580-594

---

Glucosamine alleviates liver fibrosis through modulation of sinusoidal blood flow and hepatic immune responses.

Chen X, Zhang G, Qiao Z, Zhang S, Chen L, Wang H, Qiu M, Yuan W, Liu J, Wang Z, Zhang C, Wang G
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 2025 Jul;188:118180

---

Bioengineering an improved three-dimensional vascularized co-culture model for studying Neuron-Microglia interactions.

Han Y, Guo L, Wang M, Cao Z, Zheng X, Wang X, Jin L, Wei X, Wang X, Zhao J
Bioactive materials 2025 Dec;54:813-828

---

Asiatic acid inhibits endothelial-to-mesenchymal transition in diabetic kidney disease by reducing acetyl-CoA production via targeting ACSS2.

Lin RH, Chen JC, Xu SS, Xu YY, Pan K, Wang L, Zhang J, Yin ZQ, Huang YP
Biochemical pharmacology 2025 Dec;242(Pt 2):117311

---

Enhanced viability and functional maturity of iPSC-derived islet organoids by collagen-VI-enriched ECM scaffolds.

Zhu D, Chen Z, Guo K, Xie Q, Zou Y, Mou Q, Zhou Z, Jin G
Cell stem cell 2025 Apr 3;32(4):547-563.e7

---

Melatonin inhibits circadian gene DEC1 and TLR2/MyD88/NF-κB signaling pathway to alleviate renal injury in type 2 diabetic mice.

Xu YY, Chen T, Ding H, Chen Q, Fan QL
Acta diabetologica 2024 Nov;61(11):1455-1474

---

Co-exposure of polyvinyl chloride microplastics with cadmium promotes nonalcoholic fatty liver disease in female ducks through oxidative stress and glycolipid accumulation.

Chen Y, Jin H, Ali W, Zhuang T, Sun J, Wang T, Song J, Ma Y, Yuan Y, Bian J, Liu Z, Zou H
Poultry science 2024 Nov;103(11):104152

---

Targeting the HSP47-collagen axis inhibits brain metastasis by reversing M2 microglial polarization and restoring anti-tumor immunity.

Wang L, Li C, Zhan H, Li S, Zeng K, Xu C, Zou Y, Xie Y, Zhan Z, Yin S, Zeng Y, Chen X, Lv G, Han Z, Zhou D, Zhou D, Yang Y, Zhou A
Cell reports. Medicine 2024 May 21;5(5):101533

---

Discovery of non-genomic drivers of YAP signaling modulating the cell plasticity in CRC tumor lines.

Ogasawara N, Kano Y, Yoneyama Y, Kobayashi S, Watanabe S, Kirino S, Velez-Bravo FD, Hong Y, Ostapiuk A, Lutsik P, Onishi I, Yamauchi S, Hiraguri Y, Ito G, Kinugasa Y, Ohashi K, Watanabe M, Okamoto R, Tejpar S, Yui S
iScience 2024 Mar 15;27(3):109247

---

In silico prediction and experimental validation to reveal the protective mechanism of Puerarin against excessive extracellular matrix accumulation through inhibiting ferroptosis in diabetic nephropathy.

Hou B, Ma P, Yang X, Zhao X, Zhang L, Zhao Y, He P, Zhang L, Du G, Qiang G
Journal of ethnopharmacology 2024 Jan 30;319(Pt 2):117281

---

Early rhombic lip Protogenin(+ve) stem cells in a human-specific neurovascular niche initiate and maintain group 3 medulloblastoma.

Visvanathan A, Saulnier O, Chen C, Haldipur P, Orisme W, Delaidelli A, Shin S, Millman J, Bryant A, Abeysundara N, Wu X, Hendrikse LD, Patil V, Bashardanesh Z, Golser J, Livingston BG, Nakashima T, Funakoshi Y, Ong W, Rasnitsyn A, Aldinger KA, Richman CM, Van Ommeren R, Lee JJY, Ly M, Vladoiu MC, Kharas K, Balin P, Erickson AW, Fong V, Zhang J, Suárez RA, Wang H, Huang N, Pallota JG, Douglas T, Haapasalo J, Razavi F, Silvestri E, Sirbu O, Worme S, Kameda-Smith MM, Wu X, Daniels C, MichaelRaj AK, Bhaduri A, Schramek D, Suzuki H, Garzia L, Ahmed N, Kleinman CL, Stein LD, Dirks P, Dunham C, Jabado N, Rich JN, Li W, Sorensen PH, Wechsler-Reya RJ, Weiss WA, Millen KJ, Ellison DW, Dimitrov DS, Taylor MD
Cell 2024 Aug 22;187(17):4733-4750.e26

---

Mining host candidate regulators of schistosomiasis-induced liver fibrosis in response to artesunate therapy through transcriptomics approach.

Yuan Y, Lv X, Wu Y, Weng Y, Dai F, Ding H, Chen R, Zheng B, Zhao W, Tong Q, Ding J, Lou D, Lai Y, Chu X, Zhao L, Lu S, Kong Q
PLoS neglected tropical diseases 2023 Sep;17(9):e0011626

---

Berberine protects against chronic cerebral hypoperfusion-induced cognitive impairment and hippocampal damage via regulation of the ERK/Nrf2 pathway.

Wang N, Tian Y, Yan F, Zhao F, Wang R, Luo Y, Zheng Y
Journal of chemical neuroanatomy 2022 Sep;123:102119

---

Sirt1 activation prevents anti-Thy 1.1 mesangial proliferative glomerulonephritis in the rat through the Nrf2/ARE pathway.

Huang K, Li R, Wei W
European journal of pharmacology 2018 Aug 5;832:138-144